IGF1 and neoplasm: Management of a patient with treatment-resistant acromegaly is challenging, requiring a comprehensive multidisciplinary approach considering patient characteristics (IGF-1 and GH levels, tumor size and invasiveness, symptoms and comorbidities, patient preference, and the cost-benefit ratio of the treatment).